-
UK plans to ban single-use plastic plates, cutlery and cups
Time of Update: 2023-01-12
The UK government has announced plans to ban single-use plastic cutlery, plates and polystyrene cups in England .
The UK government has announced plans to ban single-use plastic cutlery, plates and polystyrene cups in England .
-
The UK's single-day wind power generation reached a record high of 14.3 GW
Time of Update: 2022-12-26
Wind power accounted for 35.
Wind power accounted for 35.
Wind power accounted for 35.
Wind power accounted for 35.
Wind power accounted for 35.
Wind power accounted for 35.
7 per cent of UK electricity on Saturday, natural gas 20.
-
By the end of 2020, the UK will eliminate more than 1 billion problematic single-use plastics
Time of Update: 2022-08-21
1 billion problematic and unnecessary single-use plastics, and most members have already eliminated several categories of items such as drinking straws and cotton swabs By the end of 2020, members of the convention will remove a total of 1.
-
The UK has introduced an anti-CGRP single anti-Ajovy pre-filled pen for migraines: patients can inject themselves.
Time of Update: 2020-10-04
Teva UK has launched Ajovy's pre-filled pen in the UK, providing migraine sufferers with a more convenient and flexible way to do it than syringes and can manage it at home.
pre-filled pen is easy to self-manage and enhances patients' control over their condition.
-
NICE UK has approved for the first time a single anti-Stelara targeting IL-12/IL-23 for the treatment of ulcerative colitis.
Time of Update: 2020-10-02
The National Institute for Health and Clinical Excellence (NICE) has approved Janssen's Stelara (ustekinumab) for the treatment of adult patients with moderate to severe active ulcerative colitis (UC) who are insatiable to conventional therapies or biologics, who do not respond or lose their response after treatment.
-
PD-L1 Single Anti-Bavencio plus Asitini: Recommended by NICE in the UK as a first-line treatment for advanced kidney cancer.
Time of Update: 2020-08-06
The National Institute for Health and Care Excellence (NICE) recommends that Merck and Pfizer's immunotherapy bavenio (avelumib) be combined with Inlyta (axinitib) for first-line treatment syntil-end renal cell carcinoma (RCC).
-
There were 938 new deaths in the UK, with the number of deaths in the UK surpassing Italy's single-day record.
Time of Update: 2020-08-04
938 new cases of pneumonia in the UNITED Kingdom on the 8th, surpassing the highest single-day death in Italy during the worst of the outbreak of 919.
-
NICE UK approves Roche's PD-L1 single anti-Tecentriq treatment for triple-negative breast cancer after offering big discount
Time of Update: 2020-06-16
The National Institute of Health and Clinical Excellence (NICE) has approved its immunotherapy PD-L1 monoantiticriq (atezolizumab) for the treatment of triple-negative breast cancer (TNBC) patients a
-
Atta single anti-nab-purple alcohol combination approved in the UK for treatment of triple-negative breast cancer
Time of Update: 2020-06-05
The National Institute for Health and Clinical Excellence (NICE) has approved a new immunotherapy to treat some adults in the UK with triple-negative breast cancer Using a combination of Atezolizumab